June 27 (Reuters) - A panel of outside experts to the U.S. Centers for Disease Control and Prevention has recommended the use of updated COVID-19 vaccines as authorized by the FDA in persons six months and older for the 2024-25 immunization campaign. (Reporting by Christy Santhosh and Mariam Sunny in Bengaluru; Editing by Pooja Desai)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.66 USD | -1.33% | -9.57% | +163.75% |
28/06 | Novavax: ACIP in favor of Covid 24/25 vaccine | CF |
27/06 | US CDC advisers recommend updated COVID vaccines for those six months and older | RE |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
118.8 USD | -2.01% | -10.98% | 4.55TCr | ||
12.66 USD | -1.33% | -9.57% | 177.77Cr | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+163.75% | 177.77Cr | |
+19.41% | 4.55TCr | |
+38.65% | 3.81TCr | |
-8.62% | 3.85TCr | |
+26.95% | 3.07TCr | |
-13.50% | 2.6TCr | |
+10.74% | 2.59TCr | |
+44.87% | 1.41TCr | |
+34.36% | 1.27TCr | |
-7.14% | 1.13TCr |
- Stock Market
- Equities
- NVAX Stock
- News Novavax, Inc.
- US CDC advisers recommend updated COVID vaccines for those six months and older